|
|
.
See Category: Diseases of the genitourinary system
See Header: Endometrial hyperplasia
ICD-10 (CM) Code and Descriptor
|
N85.02 |
Endometrial intraepithelial neoplasia [EIN]
Diagnosis Valid for Female Patient Only
|
N8502 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 64.14%
|
18.75%
|
6.47%
|
3.27%
|
2.18%
|
1.15%
|
0.85%
|
0.67%
|
0.48%
|
0.58%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N85.02*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,481
|
1,488
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,257
|
2,232
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,221
|
38,022
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,219
|
5,628
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,165
|
1,435
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
989
|
997
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
920
|
6,321
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
870
|
3,033
|
|
86900
|
BLOOD TYPING SEROLOGIC ABO |
811
|
835
|
|
86901
|
BLOOD TYPING SEROLOGIC RH(D) |
800
|
822
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
768
|
4,701
|
|
86850
|
RBC ANTIBODY SCREEN |
731
|
738
|
|
J1885
|
KETOROLAC TROMETHAMINE INJ |
703
|
1,248
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
674
|
1,374
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
649
|
651
|
|
58571
|
TLH W/T/O 250 G OR LESS |
641
|
641
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
636
|
2,814
|
|
J7120
|
RINGERS LACTATE INFUSION |
604
|
945
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
577
|
849
|
|
85027
|
COMPLETE CBC AUTOMATED |
549
|
553
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N85.02 related to the following DRG Codes:
742-743
760-761
|
